引用本文
  • 李红梅,唐兆生,冯波.诺和锐30短期治疗对初发2型糖尿病患者胰岛β细胞功能的影响[J].同济大学学报(医学版),2013,34(4):61-63.    [点击复制]
  • LI Hong-mei,TANG Zhao-sheng,FENG Bo.Effects of short-term Aspart 30 treatment on pancreatic β-cell function in patients with newly-diagnosed type 2 diabetes[J].同济大学学报(医学版),2013,34(4):61-63.   [点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 325次   下载 322 本文二维码信息
码上扫一扫!
诺和锐30短期治疗对初发2型糖尿病患者胰岛β细胞功能的影响
李红梅,唐兆生,冯波
0
(同济大学附属东方医院内分泌科,上海200120)
摘要:
目的探讨诺和锐30短期治疗对初发2型糖尿病患者胰岛β细胞功能和血糖控制的影响。方法采用自身对照的方法,对49例新诊断未治疗的2型糖尿病患者给予3个月的诺和锐30治疗,分析比较治疗前后血糖、胰岛素、C肽和胰岛素分泌功能各指标的变化。结果治疗后,空腹血糖、2h血糖、糖化血红蛋白均明显下降,胰岛素分泌指数、胰岛素敏感指数均明显升高。胰岛素抵抗指数明显下降。结论诺和锐30治疗3个月可显著改善初发2型糖尿病患者的β细胞分泌功能和胰岛素敏感性,减轻胰岛素抵抗,改善糖代谢。
关键词:  2型糖尿病  诺和锐30  胰岛β细胞功能
DOI:10.3969/j. issnl008 -0392.2013.04.014
基金项目:
Effects of short-term Aspart 30 treatment on pancreatic β-cell function in patients with newly-diagnosed type 2 diabetes
LI Hong-mei,TANG Zhao-sheng,FENG Bo
(Dept. of Endocrinology, East Hospital, Tongji University, Shanghai 200120, China)
Abstract:
Objective To investigate the effects of short-term Aspart 30 treatment on pancreatic β- cell function and blood glucose control in patients with newly-diagnosed type 2 diabetes. Methods Forty nine patients with newly-diagnosed type 2 diabetes received Aspart 30 for three months. Levels in blood glucose, insulin, C-peptide were measured before and after treatmen. Results After treatment, fasting glucose, 2 h glucose and HbA1C were decreased significantly, insulin secretion index and insulin sensitivity index were significantly increased. Insulin resistance index decreased significantly. Conclusion Aspart 30 can significantly improve the β-cell secretory function, insulin sensitivity and glucose control in patients with newly-diagnosed type 2 diabetes.
Key words:  type 2 diabetes  Aspart 30  islet β-cell function

您是第5113476位访问者
版权所有《同济大学学报(医学版)》编辑部
主管单位:教育部 主办单位:同济大学
地  址: 上海四平路1239号 邮编:200092 电话:021-65980705 E-mail: yxxb@tongji.edu.cn
本系统由北京勤云科技发展有限公司设计